FDA Updates Articles
The U.S. Food and Drug Administration has approved Erleada (apalutamide) to treat men with prostate cancer that has not yet spread but has a quickly rising PSA level while on treatment with hormone therapy, which causes concern for cancer growth and spread.
The Food and Drug Administration has revised its recommendations for testing blood donations for the Zika virus.
